{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:29:11Z","timestamp":1763036951835},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,9]],"date-time":"2015-08-09T00:00:00Z","timestamp":1439078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00292-016-0140-5","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T12:38:50Z","timestamp":1453984730000},"page":"91-106","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thymustumoren"],"prefix":"10.1007","volume":"37","author":[{"given":"H.","family":"Grosch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-A.","family":"Weis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,9]]},"reference":[{"key":"140_CR1","doi-asserted-by":"crossref","unstructured":"Engels EA (2010) Epidemiology of thymoma and associated malignancies. J Thorac Oncol [Suppl 4] 10:260\u2013265","DOI":"10.1097\/JTO.0b013e3181f1f62d"},{"key":"140_CR2","unstructured":"Travis WD, Brambilla E, Muller-Hermelink HK (Hrsg) (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC, Lyon"},{"key":"140_CR3","doi-asserted-by":"crossref","unstructured":"Detterbeck F, Stratton K (2014) The IASLC\/ITMIG thymic epithelial tumors staging project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol [Suppl 2] 9:65\u201372","DOI":"10.1097\/JTO.0000000000000290"},{"key":"140_CR4","doi-asserted-by":"crossref","unstructured":"Marom EM (2010) Imaging thymoma. J Thorac Oncol [Suppl 4] 10:296\u2013303","DOI":"10.1097\/JTO.0b013e3181f209ca"},{"key":"140_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-989430","volume":"56","author":"Rieker","year":"2008","unstructured":"Rieker RJ, Muley T (2008) An institutional study on thymomas and thymic carcinomas: experience in 77 patients. Thorac Cardiovasc Surg 56:143\u2013147","journal-title":"Thorac Cardiovasc Surg"},{"key":"140_CR6","doi-asserted-by":"crossref","unstructured":"Marx A, Hohenberger P (2010) The autoimmune regulator AIRE in thymoma biology autoimmunity and beyond. J Thorac Oncol [Suppl 4] 10:266\u2013272","DOI":"10.1097\/JTO.0b013e3181f1f63f"},{"key":"140_CR7","doi-asserted-by":"crossref","unstructured":"Detterbeck FC (2010) Evaluation and treatment of stage I and II thymoma. J Thorac Oncol [Suppl 4] 10:318\u2013322","DOI":"10.1097\/JTO.0b013e3181f20dab"},{"key":"140_CR8","doi-asserted-by":"crossref","unstructured":"Wright CD (2010) Extended resections of thymic malignancies. J Thorac Oncol [Suppl 4] 10:344\u2013347","DOI":"10.1097\/JTO.0b013e3181f20eb3"},{"key":"140_CR9","doi-asserted-by":"crossref","unstructured":"Lucchi M, Mussi AD (2010) Surgical treatment of recurrent thymomas. J Thorac Oncol [Suppl 4] 10:348\u2013351","DOI":"10.1097\/JTO.0b013e3181f20f27"},{"key":"140_CR10","doi-asserted-by":"crossref","unstructured":"Gomez D, Komaki R (2010) Technical advances of radiation therapy for thymic malignancies. J Thorac Oncol [Suppl 4] 10:336\u2013343","DOI":"10.1097\/JTO.0b013e3181f20ea2"},{"key":"140_CR11","doi-asserted-by":"crossref","unstructured":"Fuller CD, Ramahi EH (2010) Radiotherapy for thymic neoplasms. J Thorac Oncol [Suppl 4] 10:327\u2013335","DOI":"10.1097\/JTO.0b013e3181f20ec4"},{"key":"140_CR12","doi-asserted-by":"crossref","unstructured":"Riely GJ, Huang J (2010) Induction therapy for locally advanced thymoma. J Thorac Oncol [Suppl 4] 10:323\u2013326","DOI":"10.1097\/JTO.0b013e3181f20e90"},{"key":"140_CR13","doi-asserted-by":"crossref","unstructured":"Schmitt J (2010) The role of chemotherapy in advanced thymoma. J Thorac Oncol [Suppl 4] 10:357\u2013360","DOI":"10.1097\/JTO.0b013e3181f21129"},{"key":"140_CR14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.athoracsur.2007.08.051","volume":"85","author":"Wright","year":"2008","unstructured":"Wright CD, Choi NC (2008) Induction chemoradiotherapy followed by resection for locally advanced Massaoka stage III and IVa thymic tumors. Ann Thorac Surg 85:385\u2013389","journal-title":"Ann Thorac Surg"},{"key":"140_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2003.09.022","volume":"44","author":"Bretti","year":"2004","unstructured":"Bretti S, Berrutti A (2004) Multimodal management of stages III and IVa malignant thymoma. Lung Cancer 44:69\u201377","journal-title":"Lung Cancer"},{"key":"140_CR16","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.athoracsur.2004.12.047","volume":"79","author":"Lucchi","year":"2005","unstructured":"Lucchi M, Ambrogi MC (2005) Advanced stage thymomas and thymic carciomas: results of multimodality treatments. Ann Thorac Surg 79:1840\u20131844","journal-title":"Ann Thorac Surg"},{"key":"140_CR17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","volume":"44","author":"Kim","year":"2004","unstructured":"Kim ES, Putnam JB (2004) Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44:369\u2013379","journal-title":"Lung Cancer"},{"key":"140_CR18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-5223(19)34092-9","volume":"106","author":"Rea","year":"1993","unstructured":"Rea F, Sartory F (1993) Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 106:543\u2013549","journal-title":"J Thorac Cardiovasc Surg"},{"key":"140_CR19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0003-4975(01)02786-2","volume":"72","author":"Refaley","year":"2001","unstructured":"Refaley Y, Simansky DA (2001) Resection and perfusion thermochemotherapy: a new approach for the treatment of thymic malignancies with pleural spread. Ann Thorac Surg 72:366\u2013370","journal-title":"Ann Thorac Surg"},{"key":"140_CR20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ejcts\/ezs418","volume":"43","author":"Ried","year":"2013","unstructured":"Ried M, Potzger T (2013) Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours. Perioperative management and clinical experience. Eur J Cardiothorac Surg 43:801\u2013807","journal-title":"Eur J Cardiothorac Surg"},{"key":"140_CR21","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","volume":"12","author":"Loehrer","year":"1994","unstructured":"Loehrer PJ, Kim K (1994) Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results from an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 12:1164\u20131168","journal-title":"J Clin Oncol"},{"key":"140_CR22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4","volume":"68","author":"Fornasiero","year":"1991","unstructured":"Fornasiero A, Danielle O (1991) Chemotherapy for invasive thymoma: a 13 year experience. Cancer 68:30\u201333","journal-title":"Cancer"},{"key":"140_CR23","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","volume":"14","author":"Giaccone","year":"1996","unstructured":"Giaccone GA, Ardizzoni A (1996) Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Groups. J Clin Oncol 14:814\u2013820","journal-title":"J Clin Oncol"},{"key":"140_CR24","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/jco.2008.26.15_suppl.8018","volume":"26","author":"Lemma","year":"2008","unstructured":"Lemma GL, Loehrer PJ (2008) A phase II study of carboplatin plus paclitaxel in advanced thymoma or thymic carcinoma. E1C99. Proc Ann Soc Clin Oncol 26:8018","journal-title":"Proc Ann Soc Clin Oncol"},{"key":"140_CR25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","volume":"22","author":"Loehrer","year":"2004","unstructured":"Loehrer PJ, Wang W (2004) Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma. J Clin Oncol 22:293\u2013299","journal-title":"J Clin Oncol"},{"key":"140_CR26","doi-asserted-by":"crossref","unstructured":"Kurup A, Burns M (2005) Phase II study of gefitinib in advanced thymic malignancies (abstract). J Clin Oncol [Suppl 16] 23:7068","DOI":"10.1200\/jco.2005.23.16_suppl.7068"},{"key":"140_CR27","doi-asserted-by":"crossref","unstructured":"Bedano P, Perkins S (2008) A phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma (abstract). J Clin Oncol [Suppl] 26:19087","DOI":"10.1200\/jco.2008.26.15_suppl.19087"},{"key":"140_CR28","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1200\/jco.2008.26.15_suppl.8116","volume":"26","author":"Salter","year":"2008","unstructured":"Salter JT, Lewis D (2008) Imatinib for the treatment of thymic carcinoma (meeting abstracts). J Clin Oncol 26:8116","journal-title":"J Clin Oncol"},{"key":"140_CR29","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/JTO.0b013e3181b6be57","volume":"4","author":"Giaccone","year":"2009","unstructured":"Giaccone G, Rajan A (2009) Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas. J Thorac Oncol 4:1270\u20131273","journal-title":"J Thorac Oncol"},{"key":"140_CR30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.bjc.6605740","volume":"103","author":"Strobel","year":"2010","unstructured":"Strobel P, Bargou R (2010) Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience. Br J Cancer 103:196\u2013200","journal-title":"Br J Cancer"},{"key":"140_CR31","doi-asserted-by":"crossref","unstructured":"Thomas A, Rajan A (2014) A phase II trial of sunitinib in patients with thymic epithelial tumors (TET). Poster highlight session (Poster 7525). ASCO, Chicago","DOI":"10.1200\/jco.2014.32.15_suppl.7525"},{"key":"140_CR32","doi-asserted-by":"crossref","unstructured":"Zucali PA, De Pas TM (2014) Phase II study with everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy. Poster 7527. ASCO, Chicago","DOI":"10.1200\/jco.2014.32.15_suppl.7527"},{"key":"140_CR33","doi-asserted-by":"crossref","unstructured":"Buonerba C, Ottaviano M (2014) Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a phase II trial. Poster 7528. ASCO, Chicago","DOI":"10.1200\/jco.2014.32.15_suppl.7528"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-016-0140-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-016-0140-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-016-0140-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T14:13:43Z","timestamp":1600092823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-016-0140-5"}},"subtitle":["Eine klinische Betrachtung"],"short-title":[],"issued":{"date-parts":[[2015,8,9]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["140"],"URL":"https:\/\/doi.org\/10.1007\/s00292-016-0140-5","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,9]]}}}